EARLY DIAGNOSIS AND FORECASTING OF COMPLICATIONS OF HEMORRHAGIC INSULT IN PATIENTS WITH COMORBID FOND DISEASE (REVIEW)
Keywords:
hemorrhagic stroke, biomarkers, hypertension, diabetes mellitusAbstract
Strokes with rupture of blood vessels in the brain are called hemorrhagic strokes. Despite the fact that hemorrhagic stroke is less common than ischemic stroke, the incidence of disability and mortality from them is significantly higher. Hemorrhagic strokes account for approximately 13% of all strokes. In the USA, the United Kingdom, and Australia, this figure is 8-15%, and in Korea and Japan - 18-24%. Annually, hemorrhagic strokes account for an average of 12-15% per 100,000 population. Also, the probability of hemorrhagic stroke is high in low- and middle-low-income countries and Asian countries. Especially in recent years, the incidence of the disease has become dominant in African and Asian countries, leading to a further deterioration of the country's economic and social situation and premature death. One of the worst and early complications of hemorrhagic stroke is mortality, which is 25-30% in developed countries and 30-48% in developing and low-income countries. Vascular pathologies, cerebral amyloid angiopathy, arterial hypertension, impaired hemoreology, various inflammatory diseases, diabetes mellitus, and other risk factors contribute significantly to the development of hemorrhagic stroke.
References
1. Risk factors and predictors among adult patients of ischemic and hemorrhagic stroke: A systematic review. Rajshree Devi Serum, Charuta Gadkadi, Aditya Pundkar February 14, 2025
2. Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke. Yinghua Jiang, Jinrui Han, Pierce Spencer, Yadan Li .
3. Comorbidity in Stroke-Survivors: Prevalence and Associations with Functional Outcomes and Health. Peter Appelros MD, PhD, Marie Matérne SW, PhD, Gustav Jarl CPO, PhD, Mialinn Arvidsson-Lindvall RPt, PhD. Journal of Stroke and …, 2021 – Elsevier
4. Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke. Tim Honegger, Juliane Schweizer, Antonela Bicvic. European Stroke JournalVolume 8, Issue 1, March 2023, Pages 309-319 European Stroke Organisation 2022, Article Reuse Guidelines
5. Молекулярные маркеры геморрагического инсульта. А. М. Голубев1,3, А. В. Гречко2, М. А. Говорухина. DOI: 10.15360/1813-9779-2020-3-34-45. Clinical Studies and Practice
6. Chen S, Zeng L, Hu Z. Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol. 2014 Nov;261(11):2061-78. [PMC free article: PMC4221651 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221651/)]
7. Ojaghihaghighi S, Vahdati SS, Mikaeilpour A, Ramouz A. Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke. World J Emerg Med. 2017;8(1):34-38. [PMC free article: PMC5263033]
8. An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10.
9. NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan, Hemorrhagic Stroke. Ajaya Kumar A. Unnithan1; Joe M. Das2; Parth Mehta.
10. Raximbaeva G.S., Muratov F.X., Yakubova M.M., Nevrologiya, 106-115 b., Toshkent, 2020-yil.
11. Ibodullaev Z.R., Asab kasalliklari, 75-87 b., Fan va texnologiya, Toshkent, 2013-yil.
